Impact of baseline characteristics on the efficacy of once‐weekly subcutaneous semaglutide among participants with type 2 diabetes : A post hoc analysis of SUSTAIN China
These results support the effectiveness of once-weekly subcutaneous semaglutide 0.5 and 1.0 mg across a broad range of baseline characteristics, in participants with T2D from SUSTAIN China.
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
无极微光
嘻嘻哈哈
干净的琦
lizishu
殷勤的紫槐
ephore
Twonej
仰望喀纳斯的星空
Singularity
Criminology34
乐空思
pluto
非而者厚
科研狗
rosalieshi
麦子
JJF
GingerF
kakaable
皖公网安备34019202002308
